HIVE Digital Technologies Achieves 58% Peak Hashrate Growth in One Month, Surpasses 10 EH/s in May 2025, and Remains on Track to Reach 25 EH/s by Year-End
Newsfile· 2025-06-06 05:33
HIVE Digital Technologies Achieves 58% Peak Hashrate Growth in One Month, Surpasses 10 EH/s in May 2025, and Remains on Track to Reach 25 EH/s by Year-EndJune 06, 2025 1:34 AM EDT | Source: HIVE Digital Technologies Ltd.This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated May 14, 2025, to its short form base shelf prospectus dated September 11, 2024.San Antonio, Texas--(Newsfile Corp. - June 6, 2025) - HIVE ...
Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
GlobeNewswire· 2025-06-06 05:30
Press Release Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representativeJune 6, 2025 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, reminds its shareholders that the Ordinary and Extraordinary General Meeting will be held on Friday, June 27, 2025 at 2:30 p.m., at the Company’s headquarters located at Sundesk Sophia Antipolis, rue Evariste Ga ...
BW Energy: Fixed Income Investor Meetings
GlobeNewswire· 2025-06-06 05:30
Fixed Income Investor Meetings 06 June 2025 BW Energy has engaged Pareto Securities as Global Coordinator together with Arctic Securities as Joint Bookrunners to arrange a series of fixed income investor meetings. Fearnley Securities and Sparebank1 Markets are acting as Co-Managers. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue of USD 300 million with a tenor of five years may follow. The purpose of the bond issue is for general corporate purposes. Holder ...
Publication of a transparency notification
GlobeNewswire· 2025-06-06 05:10
Publication of a transparency notification(in accordance with the Law of 2 May 2007 on disclosure of major holdings) On 4 June 2025, NV Bekaert SA crossed the threshold of 5%. Reason for the notification: passive crossing of a thresholdNotification by a parent undertaking or a controlling personPersons subject to the notification requirement: Stichting Administratiekantoor Bekaert, Chasséveld 1, 4811 DH Breda, NederlandNV Bekaert SA, Bekaertstraat 2, 8550 Zwevegem Date on which the threshold is crossed: 4 ...
Transparency Law
GlobeNewswire· 2025-06-06 05:05
Transparency LawDisclosure in accordance with the Law of 2 May 2007 Pursuant to Articles 15 §1 and 18 §1 of the Law of 2 May 2007 on the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market, NV Bekaert SA (“Bekaert”) publishes the following information: Status as of 4 June 2025 Basic data Total capital: € 159 782 000.00 Total number of securities conferring voting rights: 52 701 148 shares Total number of voting rights (the denominator): 52 701 148 (one voting r ...
TGS Commences Ultra-High Resolution 3D Seismic Survey for Green Volt Wind Development
GlobeNewswire· 2025-06-06 05:00
London, United Kingdom (06 June 2025) – TGS, a leading global provider of energy data and intelligence has commenced a geophysical survey for the pioneering Green Volt floating offshore wind farm. Mobilization initiated in Aberdeen last week and the work scheduled throughout June will include an ultra-high resolution 3D (UHR3D) seismic survey used to deliver detailed subsurface data for the floating wind farm’s site characterization. The Green Volt project is a joint venture between leading offshore wind d ...
Idorsia publishes invitations to bondholder meetings
GlobeNewswire· 2025-06-06 05:00
Ad hoc announcement pursuant to Art. 53 LR Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025 and CB 2028 Allschwil, Switzerland – June 6, 2025Idorsia Ltd (SIX: IDIA) today announced that following the expiry of the appeal period for the amended terms approved at the CB 2025 bondholder meeting of February 25, 2025 – during which no appeal was filed – it has published invitations to the next bondholder mee ...
Dassault Systèmes: Doubling EPS by 2029, 3D UNIV+RSES creating new growth opportunities
GlobeNewswire· 2025-06-06 05:00
Press ReleaseVELIZY-VILLACOUBLAY — June 6, 2025 Dassault Systèmes: Doubling EPS by 2029,3D UNIV+RSES creating new growth opportunities Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) hosts its 2025 Capital Markets Day at its headquarters in Vélizy-Villacoublay, France, today, June 6, 2025. The event, dedicated to financial analysts and investors, features a series of presentations by the Company’s executive management. It highlights how 3D UNIV+RSES mark a fundamental shift, providing the next gene ...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
GlobeNewswire News Room· 2025-06-06 05:00
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs. Some of ...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
GlobeNewswire· 2025-06-06 05:00
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs. Some of ...